Could poop transplants spare kids with Crohn's from strong drugs?

NCT ID NCT05321758

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study tests whether repeated fecal microbiota transplants (FMT) combined with a special liquid diet can safely control active Crohn's disease in children aged 2–16 who are newly diagnosed. The goal is to see if this approach can achieve remission and heal the gut lining without using standard immunosuppressive drugs. Fifty children will receive multiple FMT courses along with partial enteral nutrition, and their outcomes will be measured by symptom scores and colonoscopy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Fecal microbiota transplantation (FMT) plus partial enteral nutrition
What this could lead to
If successful, this approach could offer a drug-sparing first-line treatment for children with Crohn's disease, potentially reducing the need for immunosuppressants.
What could go wrong
This is a small, early-phase study with no control group, so results may not be conclusive. FMT carries risks like fever, abdominal pain, or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tongji Hospital

    RECRUITING

    Wuhan, Hubei, 430030, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.